Skip to Main Content

Author Details

Maud H W Starmans
Ontario Institute for Cancer Research
2006
31
18
PMIDPaper TitleJournal TitlePublished Year
30665349BPG: Seamless, automated and interactive visualization of scientific data.BMC Bioinformatics2019
31106127Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort.Transl Lung Cancer Res2019
30420699Pathway-based subnetworks enable cross-disease biomarker discovery.Nat Commun2018
27750381Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.Int J Cancer2017
29088766Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer.Oncotarget2017
25314936The transcriptomic profile of ovarian cancer grading.Cancer Med2015
26041263How do changes in the mtDNA and mitochondrial dysfunction influence cancer and cancer therapy? Challenges, opportunities and models.Mutat Res Rev Mutat Res2015
25826681Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.PLoS One2015
26021974Biomarkers and subtypes of cancer.Aging (Albany NY)2015
26005866Spatial genomic heterogeneity within localized, multifocal prostate cancer.Nat Genet2015
25609067Integrating RAS status into prognostic signatures for adenocarcinomas of the lung.Clin Cancer Res2015
24571588Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.BMC Cancer2014
25351418Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.Nat Commun2014
24902696Ensemble analyses improve signatures of tumour hypoxia and reveal inter-platform differences.BMC Bioinformatics2014
24861629Epigenetics in radiotherapy: where are we heading?Radiother Oncol2014
23165123Predicting outcomes in radiation oncology--multifactorial decision support systems.Nat Rev Clin Oncol2013
24403265Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non-small cell lung cancer.Cancer Med2013
23849170The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia.Radiother Oncol2013
23935846The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.PLoS One2013
23653877A case report and genetic characterization of a massive acinic cell carcinoma of the parotid with delayed distant metastases.Case Rep Oncol Med2013
22356756The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.Radiother Oncol2012
23304554A Pilot Study Comparing HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas by Whole Exome Sequencing.ISRN Oncol2012
23146350Exploiting the noise: improving biomarkers with ensembles of data analysis methodologies.Genome Med2012
22722312Independent and functional validation of a multi-tumour-type proliferation signature.Br J Cancer2012
22163293A simple but highly effective approach to evaluate the prognostic performance of gene expression signatures.PLoS One2011
20647155The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.Radiother Oncol2010
20921041Re: Gene expression-based prognostic signatures in lung cancer: ready for clinical use?J Natl Cancer Inst2010
19615772The use of a comprehensive tumour xenograft dataset to validate gene signatures relevant for radiation response.Radiother Oncol2009
18985037Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.Br J Cancer2008
17532074Impact of supervised gene signatures of early hypoxia on patient survival.Radiother Oncol2007
16730089Palliative chest irradiation in sitting position in patients with bulky advanced lung cancer.Radiother Oncol2006
  • 1 - 31 of 31

Recommended Authors

Seyed Ali Madani Tonekaboni
Princess Margaret Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 7
Lingjian Yang
Ankang University
Career Start Year 2014
Number of shared co-authors 6
Martin Sj??str??m
University of California-San Francisco
Career Start Year 2013
Number of shared co-authors 2
Arvind Singh Mer
University of Ottawa
Career Start Year 2011
Number of shared co-authors 10
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 5
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 0
Karolina Edlund
Leibniz Research Centre for Working Environment and Human Factors at TU Dortmund
Career Start Year 2008
Number of shared co-authors 1
Yang Xie
Quantitative Biomedical Research Center
Career Start Year 2007
Number of shared co-authors 0
Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 4
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 3
Lee Trani
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 2005
Number of shared co-authors 1
Tuan Zea Tan
Cancer Science Institute of Singapore, National University of Singapore
Career Start Year 2005
Number of shared co-authors 0
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 40
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 3
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 3
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 1
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 3
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 2
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 12
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 17
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 11
Ole Christian Lingj??rde
University of Oslo
Career Start Year 1997
Number of shared co-authors 3
Patrick Micke
Uppsala University
Career Start Year 1997
Number of shared co-authors 0
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 4
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 0
Aedin C Culhane
Dana-Farber Cancer Institute & Harvard School of Public Health
Career Start Year 1996
Number of shared co-authors 0
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 13
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 13

Collaborators

Paul C Boutros
University of California los angeles
Co-authored papers 24
Philippe Lambin
Maastricht University
Co-authored papers 22
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers 9
Syed Haider
Institute of Cancer Research
Co-authored papers 8
Francis Nguyen
Ontario Institute for Cancer Research
Co-authored papers 7
Ming-Sound Tsao
University Health Network, University of Toronto
Co-authored papers 6
Thomas John
Peter MacCallum Cancer Centre
Co-authored papers 6
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers 6
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 5
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 4
Ludwig Dubois
Maastricht University
Co-authored papers 4
Igor Jurisica
Schroeder Arthritis Institute
Co-authored papers 4
Kenneth C Chu
Ontario Institute for Cancer Research
Co-authored papers 4
Sandy D Der
Toronto General Research Institute, University Health Network
Co-authored papers 4
Frances A Shepherd
University Health Network, Princess Margaret Cancer Centre
Co-authored papers 4
Arek Kasprzyk
Ontario Institute for Cancer Research
Co-authored papers 3
Adrian C Begg
The Netherlands Cancer Institute
Co-authored papers 3
Gavin M Wright
St. Vincent's Hospital, University of Melbourne
Co-authored papers 3
Renaud Seigneuric
INSERM
Co-authored papers 3
Nicholas J Harding
Big Data Institute, University of Oxford
Co-authored papers 3
Dirk De Ruysscher
Maastro Clinic
Co-authored papers 3
Natalie S Fox
University of California los angeles
Co-authored papers 3
Marzena Walkiewicz
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Daryl Waggott
Ontario Institute for Cancer Research
Co-authored papers 3
Paul Mitchell
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Jianxin Wang
Ontario Institute for Cancer Research
Co-authored papers 3
Nathalie C Moon
Ontario Institute for Cancer Research
Co-authored papers 3
Prudence A Russell
St Vincent's Hospital
Co-authored papers 2
Yu-Jia Shiah
Ontario Institute for Cancer Research
Co-authored papers 2
Cary Oberije
Maastricht University Medical Centre
Co-authored papers 2
Release 1.2